Evolving strategies for early diagnosis, proactive prevention and treatment of CKD

医学 重症监护医学 肾脏疾病 内科学
作者
Alberto Ortíz,Motoko Yanagita,Hideki Yokoi,Roser Torrá
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:41 (3): 418-427 被引量:12
标识
DOI:10.1093/ndt/gfaf151
摘要

Chronic kidney disease (CKD) is among the fastest growing global causes of death, forecasted to become the third leading cause of death in Western Europe and Japan by 2050. In contrast, mortality from cardiovascular disease is decreasing. Cardiovascular medicine is focused on identifying people at high risk and intervening to prevent cardiovascular events. The focus of kidney medicine has evolved over time. Last century the focus was on treating kidney failure by kidney replacement therapy (KRT). However, KRT outcomes are suboptimal. Life expectancy is up to 44 (women on dialysis) to 22 years (women with functioning kidney grafts) shorter on KRT than in the general population. The 21st century has witnessed an explosion of highly effective kidney-protective drugs that may both prevent and slow the progression of CKD while addressing the full cardiovascular-kidney-metabolic (CKM) syndrome spectrum, i.e. also improving cardiovascular and metabolic outcomes. However, these advances have met a barrier: 20th century concepts on whom to test for CKD, which focus on assessing albuminuria just in people with diabetes mellitus. This outdated concept limits early diagnosis and treatment in up to 80% of people who eventually develop kidney failure. Clinical trials suggest that starting kidney protective therapy because CKD was diagnosed based on albuminuria, when glomerular filtration rate is normal, may delay the need for KRT for up to nearly 3 decades, meaning that many older subjects would not require KRT. To improve outcomes, the next two steps in kidney medicine should involve the widespread adoption of the ABCDE (albuminuria, blood pressure, cholesterol, diabetes and estimated glomerular filtration rate) approach for early detection and treatment of CKM risk, followed by developing the concept of pre-CKD that may guide pharmacologic interventions targeted to prevent CKD, on top of healthy lifestyle measures for the entire population, not just for those at risk.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shaowen发布了新的文献求助10
刚刚
我不是BOB发布了新的文献求助50
刚刚
bolakun完成签到,获得积分10
刚刚
斯文败类的应助被查查make采纳,获得10
刚刚
若黎发布了新的文献求助10
1秒前
Jasper的应助被成博采纳,获得10
1秒前
牛奶咖啡完成签到,获得积分10
1秒前
在水一方的应助被alohomora100采纳,获得10
2秒前
2秒前
3秒前
徐小包完成签到,获得积分10
4秒前
4秒前
千瓦尔塔完成签到 ,获得积分10
5秒前
6秒前
在水一方的应助被风中亦绿采纳,获得10
6秒前
科研通AI6.4的应助被Lee采纳,获得50
6秒前
6秒前
小小白完成签到,获得积分10
6秒前
6秒前
7秒前
Dawn发布了新的文献求助10
7秒前
7秒前
顶顶顶发布了新的文献求助10
7秒前
寒冷勒完成签到,获得积分10
8秒前
LYing完成签到 ,获得积分10
8秒前
fff发布了新的文献求助10
8秒前
9秒前
9秒前
华仔的应助被facekima采纳,获得10
9秒前
科研小白关注了科研通微信公众号
10秒前
10秒前
11秒前
笨笨完成签到,获得积分10
12秒前
桐桐的应助被芊芊墨客采纳,获得10
12秒前
sissie完成签到,获得积分10
13秒前
荔枝完成签到 ,获得积分10
13秒前
14秒前
xx发布了新的文献求助10
14秒前
16秒前
shaowen完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 1000
Электротехническая система магнитожидкостной герметизации валов регулируемых электродвигателей 800
日本語と中国語及びチベット・ビルマ語の語源関連性に関する分析 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre 666
Mental Health 600
The Basics of Practical Optimization, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 物理 生物化学 化学工程 内科学 复合材料 催化作用 心理学 人工智能 细胞生物学 光电子学 无机化学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 7978061
求助须知:如何正确求助?哪些是违规求助? 9440922
关于积分的说明 21072973
捐赠科研通 7553591
什么是DOI,文献DOI怎么找? 3374960
关于科研通互助平台的介绍 2509577
邀请新用户注册赠送积分活动 2408005